SCHEMBL6174258

SCHEMBL6174258

CC1(Cc2cc(F)nc3ccccc23)NC(=O)N(c2ccc(S(=O)(=O)C(F)(F)F)cc2)C1=O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 2/20 0.49
AR P10275 6/20 0.38
SMN1; SMN2 Q16637 2/20 0.35
KMT2A Q03164 2/20 0.34
TP53 P04637 1/20 0.34
ADAM17 P78536 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
ITGAL P20701 1/20 0.33
LMNA P02545 2/20 0.32
HTT P42858 2/20 0.32
LIPG Q9Y5X9 1/20 0.32
MEN1 O00255 1/20 0.31
S1PR4 O95977 1/20 0.31
MAPT P10636 1/20 0.31
XBP1 P17861 1/20 0.31
S1PR1 P21453 1/20 0.31
MC4R P32245 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6173085 0.88 IGF1R (0.47) IGF1RARSMN1; SMN2KMT2ATP53
SCHEMBL6172524 0.85 IGF1R (0.45) IGF1RARSMN1; SMN2ADAM17LMNA
SCHEMBL6175292 0.85 IGF1R (0.65) IGF1RARSMN1; SMN2KMT2ATP53
SCHEMBL6171503 0.85 IGF1R (0.65) IGF1RARSMN1; SMN2KMT2ATP53
SCHEMBL6175753 0.84 IGF1R (0.42) IGF1RARITGAL
Trifluoroacetic Acid SCHEMBL17558350 0.83 IGF1R (0.60) IGF1RARSMN1; SMN2KMT2AITGAL
Trifluoroacetic Acid SCHEMBL17558459 0.83 IGF1R (0.60) IGF1RARSMN1; SMN2KMT2AITGAL
SCHEMBL2994628 0.80 IGF1R (0.74) IGF1RAR
SCHEMBL6171151 0.79 IGF1R (0.51) IGF1RARSMN1; SMN2KMT2ATP53
SCHEMBL6173676 0.78 IGF1R (0.52) IGF1RARKMT2ATP53ITGAL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed